Vorinostat: a histone deacetylases (HDAC) inhibitor ameliorates traumatic brain injury by inducing iNOS/Nrf2/ARE pathway
The present investigation evaluates the protective effect of vorinostat on neuronal cells in the traumatic brain injury (TBI) and also postulates the possible mechanism of its action. Marmarou’s weight-drop model was used to induce the TBI. Further, animals were treated with vorinostat 100 mg/kg int...
Main Authors: | Jinyu Xu, Jun Shi, Jiaming Zhang, Yun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2018-09-01
|
Series: | Folia Neuropathologica |
Subjects: | |
Online Access: | https://www.termedia.pl/Vorinostat-a-histone-deacetylases-HDAC-inhibitor-ameliorates-traumatic-brain-injury-by-inducing-iNOS-Nrf2-ARE-pathway,20,33882,1,1.html |
Similar Items
-
Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
by: Saelen Marie, et al.
Published: (2012-09-01) -
Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension
by: Tanya J. Applegate, et al.
Published: (2021-09-01) -
Effect of vorinostat on INK4 family and HDACs 1, 2, and 3 in pancreatic cancer and hepatocellular carcinoma
by: Masumeh Sanaei, et al.
Published: (2021-01-01) -
Vorinostat-An overview
by: Aditya Kumar Bubna
Published: (2015-01-01) -
Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
by: Amit Kumar Singh, et al.
Published: (2018-06-01)